2027 ICD-10-CM Diagnosis Code E65Localized adiposity
ICD-10-CM Codes›E00–E89›E65-E68›E65
- Billable — Valid for Submission
- Chronic Condition
E65 is a billable ICD-10-CM diagnosis code for localized adiposity. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 640 through 641. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Adverse reaction following injection of substance
- Excess panniculus of abdomen
- Excess subcutaneous fat
- Excess subcutaneous fat of back
- Excess subcutaneous fat of breast
- Excess subcutaneous fat of lower limb
- Excess subcutaneous fat of upper limb
- Fat hypertrophy
- Fat hypertrophy due to injection of drug or medicament
- Fat pad syndrome
- Hypertrophy of subcutaneous fatty tissue of lower limb
- Insulin adverse reaction
- Insulin lipohypertrophy
- Localized adiposity
- Steatopygia
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to E65: its own notes plus those printed at Chapter 4. A note printed at a category, block or chapter applies to every code under it.
Applicable To
Conditions this code is used for: synonyms of the title or, for "other specified" codes, the conditions assigned to it. The list is not exhaustive.
- Fat pad
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Notes
General instructions on how these codes are used.
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name E65, its category, or a range that includes it.
Index to Diseases and InjuriesGuidance
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Obesity
Obesity is a disease that means having too much body fat. It is different from being overweight, which means weighing too much. Both terms mean that your weight is greater than what's considered healthy for your height.
The full article covers:
- What is obesity?
- What raises your risk of obesity?
- How is obesity diagnosed?
- What health problems can obesity cause?
- What are the treatments for obesity?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert E65 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About E65Overview
What is the ICD-10 code for localized adiposity?
The ICD-10-CM code for localized adiposity is E65. It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is E65 (Localized adiposity) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report localized adiposity on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does E65 group to?
When localized adiposity is the principal diagnosis on an inpatient stay, it groups to MS-DRG 641, 640, with relative weights from 0.7864 to 1.3392 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of E65?
Under the General Equivalence Mappings, localized adiposity converts to ICD-9-CM 278.1 (localized adiposity). The mapping is a direct match.
